Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7171640 | 0.86 | LMNA (0.32) | LMNA | |
| SCHEMBL14997818 | 0.82 | LMNA (0.39) | LMNA | |
| SCHEMBL23542846 | 0.80 | LMNA (0.42) | LMNA | |
| SCHEMBL14997815 | 0.78 | — | — | |
| SCHEMBL6003760 | 0.76 | REV1 (0.30) | — | |
| SCHEMBL6409272 | 0.75 | LMNA (0.32) | LMNA | |
| SCHEMBL10718494 | 0.71 | LMNA (0.39) | LMNA | |
| SCHEMBL3670530 | 0.69 | LMNA (0.41) | LMNANOS1 | |
| SCHEMBL27929409 | 0.69 | TLR8 (0.44) | LMNANOS1 | |
| SCHEMBL20449075 | 0.69 | LMNA (0.36) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116922004-A | Manufacturing method of non-stick pan with wear-resistant antibacterial coating | 宁波市金象厨具有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-116922004-A | Manufacturing method of non-stick pan with wear-resistant antibacterial coating | 宁波市金象厨具有限公司 | 2023-10-24 | — | — | CN | disclosed |
| EP-3186245-B1 | MAPK INHIBITORS | EverBrilliant Pharma Pty Ltd (AU) | 2021-06-23 | — | — | EP | disclosed |
| US-20170266173-A1 | MAPK INHIBITORS | EVERBRILLIANT PHARMA PTY LTD. (AU) | 2017-09-21 | — | — | US | disclosed |
| US-20170266173-A1 | MAPK INHIBITORS | EVERBRILLIANT PHARMA PTY LTD. (AU) | 2017-09-21 | — | — | US | disclosed |
| WO-2016029263-A1 | MAPK INHIBITORS | WANG BING HUI (AU) | 2016-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170266173-A1 | MAPK INHIBITORS | MAPK1, MAPK4, MAPK3 | LMNA 4686/4885NOS1 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.